Phillips-Medisize will be showcasing its capabilities in designing, developing and manufacturing drug delivery devices at Pharmapack in Paris on 10-11 February
Bill Welch, chief technology officer, Phillips-Medisize
Products on display will range from special drug delivery devices, dosage systems, disposable insulin pens, inhalers, mixing injectors, bottles and caps, on to sterile multi-chamber bags.
On February 10, Bill Welch, chief technology officer, Phillips-Medisize, will give a lecture entitled ‘Integrated development and scale-up of combination products.’
This presentation will discuss a well-rounded approach for biopharma companies interested in developing and commercialising successful combination products, by highlighting key device development and scale-up activities as well as their relationship to the overall combination product development process according to Phillips-Medisize.
Phillips-Medisize will also give a one-hour press briefing during the Pharmapack show, which will include an industry update by Matt Jennings, chairman and CEO of the company.
Phillips-Medisize will be exhibiting at stand 616 at Pharmapack 2016. To register for the event, click here.